Effects of Two Different Applications in Fibromyalgia

Fibromyalgia Clinical Trial

Official title:

Effects of Connective Tissue Massage and Taping in Patients With Fibromyalgia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05897931
• Other study ID #: Fibromyalgia
• Status: Completed
• Phase: N/A
• Start date: June 1, 2023
• Est. completion date: July 7, 2023

Study information

• Verified date: July 2023
• Source: Biruni University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study aims to determine the effect of connective tissue massage and taping applications on the pain and depression complaints of fibromyalgia patients and to compare their impact on quality of life.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 34
• Est. completion date: July 7, 2023
• Est. primary completion date: June 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 55 Years

Eligibility

Inclusion Criteria:

• Being diagnosed with fibromyalgia.

• Be in the age range of 20 - 55 years.

• To be a volunteer participant in the research.

• Being able to communicate comfortably.

• To be able to act independently.

Exclusion Criteria:

• Having had a surgical operation within the last year.

• Presence of significant infection.

• Being diagnosed with cancer.

• Being pregnant or breastfeeding.

• Being addicted to drugs or alcohol.

• Having a cognitive problem.

Related Conditions & MeSH terms

• Fibromyalgia
• Myofascial Pain Syndromes

Intervention

Other:
• Connective tissue massage
Connective Tissue Massage will be applied by starting from the lumbosacral region, continuing from the lower thoracic region, and finishing by applying it to the scapular region, interscapular region, and cervico-occipital region.
• Kinesio Tape Application
Taping will be applied to the levator scapula and upper trapezius muscles in a "Y" shape, with 25% tension and while the participants were in an upright position. Again in the same position, this time the "C" shaped taping technique will be adhered with 50% tension from the middle fibers of the trapezium to the last rib.

Locations

Country	Name	City	State
Turkey	Yeditepe University	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Biruni University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual Analogue Scale	Visual Analogue Scale (VAS) will be used to assess pain severity. In the assessment, the patient is asked to mark pain intensity on a 10-centimeter line that no pain is 0, and the most severe pain is 10.	4 weeks
Secondary	Fibromyalgia Impact Questionnaire	The questionnaire assesses the functional status of patients with fibromyalgia. The scale consists of 20 questions that measure physical function, well-being, difficulty in doing work, not being able to go to work, fatigue, stiffness, morning fatigue, pain, anxiety, and depression separately. Low scores indicate improvement or less effect in patients.	4 weeks
Secondary	McGill Pain Questionnaire	The quality of the pain felt by the patients will be evaluated with the Short Form McGill Pain Questionnaire. The level of severity felt by the patient is evaluated with a number scale (0=no, 1=mild, 2=moderate, 3=severe), and higher scores show severe pain intensity.	4 weeks
Secondary	Beck's Depression Inventory	The Beck's Depression Inventory (BDI) is a 21-item self-assessment scale that evaluates the patients' perceived depressive symptoms quantitatively and measures the symptoms of depression. The higher scores indicate the severity of the patient's depression. It has been suggested that those who score 17 and above on the BDI may constitute an at-risk group.	4 weeks
Secondary	Short Form-36 Quality of Life Scale	The scale assesses the quality of life. The scale consists of 36 items evaluated in 8 separate subscales. The score from each subscale is between 0-100, and a higher score indicates better quality of life.	4 weeks